$2.94 Billion is the total value of Redmile Group, LLC's 81 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 145.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMGN | Buy | IMMUNOGEN INC | $119,834,000 | +17.4% | 12,315,942 | +26.9% | 4.07% | +3.3% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $87,417,000 | +31.9% | 355,009 | +3.7% | 2.97% | +16.1% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $85,852,000 | -4.3% | 2,244,507 | +0.3% | 2.92% | -15.8% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $85,157,000 | +116.6% | 2,228,656 | +70.3% | 2.89% | +90.6% |
| CLVS | New | CLOVIS ONCOLOGY INC | $79,964,000 | – | 1,758,600 | +100.0% | 2.72% | – |
| IFRX | Buy | INFLARX NV | $65,393,000 | +166.4% | 2,027,700 | +138.2% | 2.22% | +134.3% |
| QURE | New | UNIQURE NV | $61,402,000 | – | 1,624,400 | +100.0% | 2.09% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $60,747,000 | +34.6% | 489,300 | +20.9% | 2.06% | +18.5% |
| LIVN | Buy | LIVANOVA PLC | $59,871,000 | +30.5% | 599,788 | +15.7% | 2.03% | +14.9% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $58,123,000 | +253.2% | 1,477,080 | +79.9% | 1.97% | +210.4% |
| ARGX | Buy | ARGENX SEsponsored adr | $55,790,000 | +190.7% | 673,300 | +182.2% | 1.90% | +155.7% |
| LH | New | LABORATORY CORP AMER HLDGS | $51,776,000 | – | 288,400 | +100.0% | 1.76% | – |
| XERS | New | XERIS PHARMACEUTICALS INC | $45,792,000 | – | 2,412,642 | +100.0% | 1.56% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $42,141,000 | -7.6% | 268,500 | +0.5% | 1.43% | -18.7% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $39,693,000 | +3.4% | 2,957,765 | +0.1% | 1.35% | -9.1% |
| MOR | New | MORPHOSYS AGsponsored ads | $38,526,000 | – | 1,269,800 | +100.0% | 1.31% | – |
| HSKA | Buy | HESKA CORP | $36,822,000 | +95.3% | 354,776 | +48.8% | 1.25% | +71.8% |
| ANTM | New | ANTHEM INC | $34,752,000 | – | 146,000 | +100.0% | 1.18% | – |
| EHTH | Buy | EHEALTH INC | $30,451,000 | +59.9% | 1,377,895 | +3.6% | 1.03% | +40.7% |
| NITE | Buy | NIGHTSTAR THERAPEUTICS PLCadr | $28,567,000 | +12.4% | 1,785,446 | +0.9% | 0.97% | -1.2% |
| CTLT | New | CATALENT INC | $27,725,000 | – | 661,850 | +100.0% | 0.94% | – |
| EPZM | Buy | EPIZYME INC | $27,390,000 | -23.3% | 2,021,389 | +0.5% | 0.93% | -32.6% |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $27,306,000 | – | 1,750,408 | +100.0% | 0.93% | – |
| New | ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $26,083,000 | – | 25,000,000 | +100.0% | 0.89% | – | |
| New | ARRAY BIOPHARMA INCnote 2.625%12/0 | $25,524,000 | – | 19,000,000 | +100.0% | 0.87% | – | |
| ZTS | New | ZOETIS INCcl a | $21,221,000 | – | 249,100 | +100.0% | 0.72% | – |
| TCDA | New | TRICIDA INC | $14,950,000 | – | 500,000 | +100.0% | 0.51% | – |
| ODT | Buy | ODONATE THERAPEUTICS INC | $13,482,000 | +7.1% | 610,600 | +2.8% | 0.46% | -5.8% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $9,304,000 | -64.8% | 1,214,593 | +2.7% | 0.32% | -69.0% |
| SGRY | New | SURGERY PARTNERS INC | $9,257,000 | – | 621,300 | +100.0% | 0.31% | – |
| STIM | New | NEURONETICS INC | $7,983,000 | – | 300,000 | +100.0% | 0.27% | – |
| VTL | New | VITAL THERAPIES INC | $7,502,000 | – | 1,095,111 | +100.0% | 0.26% | – |
| INSP | New | INSPIRE MED SYS INC | $7,132,000 | – | 200,000 | +100.0% | 0.24% | – |
| BGNE | Buy | BEIGENE LTDsponsored adr | $6,195,000 | -7.8% | 40,300 | +0.8% | 0.21% | -18.9% |
| SENS | New | SENSEONICS HLDGS INC | $5,417,000 | – | 1,317,924 | +100.0% | 0.18% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $4,111,000 | – | 31,100 | +100.0% | 0.14% | – |
| EIDX | New | EIDOS THERAPEUTICS INC | $3,885,000 | – | 191,000 | +100.0% | 0.13% | – |
| UBX | New | UNITY BIOTECHNOLOGY INC | $3,771,000 | – | 250,400 | +100.0% | 0.13% | – |
| VCEL | New | VERICEL CORP | $1,754,000 | – | 180,873 | +100.0% | 0.06% | – |
| HZNP | Buy | HORIZON PHARMA PLC | $427,000 | +50.4% | 25,800 | +29.0% | 0.02% | +36.4% |
| MYOK | New | MYOKARDIA INC | $356,000 | – | 7,170 | +100.0% | 0.01% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $340,000 | – | 2,170 | +100.0% | 0.01% | – |
| FLXN | Buy | FLEXION THERAPEUTICS INC | $343,000 | +53.8% | 13,260 | +33.5% | 0.01% | +33.3% |
| NVRO | New | NEVRO CORP | $271,000 | – | 3,400 | +100.0% | 0.01% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $274,000 | – | 1,590 | +100.0% | 0.01% | – |
| AMED | New | AMEDISYS INC | $233,000 | – | 2,725 | +100.0% | 0.01% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTL | $208,000 | – | 8,930 | +100.0% | 0.01% | – |
| VRAY | New | VIEWRAY INC | $168,000 | – | 24,330 | +100.0% | 0.01% | – |
| CSLT | New | CASTLIGHT HEALTH INCcl b | $43,000 | – | 10,229 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-10 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.